AstraZeneca aims for a full listing in New York, but remains headquartered in the United Kingdom.
Adrian Rusu
International
Foto: shutterstock.com/ro
Always see our news on Google
AstraZeneca announced on Monday that it intends to move to a direct listing of its shares on the New York Stock Exchange, in a move aimed at capitalizing on the high appetite of American investors, but emphasized that it will not leave London.
Sources
Gigantul farmaceutic european AstraZeneca vizează listare completă la New York
AstraZeneca vizează listare completă la New York, dar îşi reafirmă angajamentul faţă de Londra
UK plc can't afford to lose AstraZeneca to Wall Street
AstraZeneca's listing rejig spells long-term danger for London | Nils Pratley
AstraZeneca trece la listare directă pe bursa din New York, dar rămâne cu sediul în Marea Britanie
Latest News
23:08
Nicușor Dan argues that anyone who repressed during the Revolution has no place in a high position, but Pahonțu is not in this situation.
22:38
A commercial ship caught fire in the Black Sea. Nicușor Dan: It was hit and seems to have sunk.
22:20
Nicușor Dan, after the trilateral meeting in Chișinău: Romania, the Republic of Moldova, and Ukraine will continue collaboration in the fields of infrastructure, energy, and security.
22:01
Péter Magyar: Paks operates at maximum capacity / The nuclear power plant in Romania, previously cited as an example, has been shut down for two weeks.
21:38
UEFA has conducted the draw for the main stage of the Champions League / Liverpool and Real for Chivu
See more news
NEWS ON THE SAME TOPICS
International
AstraZeneca, negotiations with Bristol Myers Squibb for a possible merger that could create a 400 billion dollar group
International
AstraZeneca announced the failure of a drug for a rare heart condition, causing a 9% drop in the company's shares.
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
